Home > Cashflow Statement > SHREE GANESH REMEDIES

SHREE GANESH REMEDIES
Cashflow Statement

AD     Remove this Ad

SHREE GANESH REMEDIES Last 5 Year Cashflow Statement History

[Consolidated]

Mar2025Mar2024Mar2020Mar2019
Profit Before Tax₹31 Cr₹38 Cr₹14 Cr₹8.67 Cr
Adjustment ₹11 Cr₹5.89 Cr₹-3.66 Cr₹-0.35 Cr
Changes In working Capital ₹-1.73 Cr₹-5.47 Cr₹-5.34 Cr₹-14 Cr
Cash Flow after changes in Working Capital ₹41 Cr₹39 Cr₹4.59 Cr₹-5.22 Cr
Cash Flow from Operating Activities ₹31 Cr₹30 Cr₹4.59 Cr₹-5.22 Cr
Cash Flow from Investing Activities ₹-36 Cr₹-33 Cr₹-2.91 Cr₹-0.08 Cr
Cash Flow from Financing Activities ₹-1.09 Cr₹9.84 Cr₹-0.48 Cr₹-0.18 Cr
Net Cash Inflow / Outflow ₹-6.08 Cr₹7.28 Cr₹1.20 Cr₹-5.47 Cr
Opening Cash & Cash Equivalents ₹16 Cr₹8.66 Cr₹1.13 Cr₹6.46 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger ----
Cash & Cash Equivalent of Subsidiaries under liquidations ----
Translation adjustment on reserves / op cash balalces frgn subsidiaries ----
Effect of Foreign Exchange Fluctuations ₹0.18 Cr₹-0.08 Cr--
Closing Cash & Cash Equivalent ₹9.95 Cr₹16 Cr₹2.33 Cr₹0.99 Cr

Compare Cashflow Statement of peers of SHREE GANESH REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SHREE GANESH REMEDIES ₹605.4 Cr 1.4% -7.7% -35.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,603.0 Cr -5.6% -2.5% -1.7% Stock Analytics
DIVIS LABORATORIES ₹155,485.0 Cr -2.6% -8.7% 1.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹135,009.0 Cr -7.2% -8% 27.6% Stock Analytics
DR REDDYS LABORATORIES ₹101,628.0 Cr -6.5% -5.4% 3.9% Stock Analytics
CIPLA ₹96,400.8 Cr -4.1% -11.5% -19% Stock Analytics


SHREE GANESH REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SHREE GANESH REMEDIES

1.4%

-7.7%

-35.4%

SENSEX

-1%

-10.9%

-6%


You may also like the below Video Courses